Improving respiratory vaccination rates in COPD and asthma through education

Improving respiratory vaccination rates in COPD and asthma

Targeted education programmes significantly increase immunisation uptake, but inconsistent data collection has historically masked which methods actually work. Despite clear clinical guidelines, respiratory vaccination rates in COPD and asthma lag behind targets, leaving vulnerable populations exposed to preventable exacerbations. This systematic review of 11 studies examined how to bridge the gap between medical advice and patient action.

Researchers analysed data from four randomised trials and seven observational studies using the COM-B behaviour change framework. They found that interventions focusing on 'capability'—specifically increasing the knowledge of both patients and healthcare professionals—resulted in statistically significant increases in influenza and pneumococcal vaccination. Nine of the eleven studies reported positive outcomes when education was the primary tool.

Compared to simple automated reminders, structured educational programmes provide the necessary context for patients to organise their care and prioritise immunisation. However, the rigour of this field is questionable; most included studies carried a high risk of bias, preventing a formal meta-analysis. This lack of standardisation hinders the development of a universal protocol for clinics.

Future efforts must move beyond knowledge and address 'physical opportunity', particularly in low-income economies where the burden of respiratory disease is highest. This review does not address the specific barriers to COVID-19 vaccination or how to sustain these improvements over multiple seasons.